Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927976 · ClinicalTrials.gov registry record · NA
Feasibility of a Culturally-Specific Video Text Cessation Intervention With AA Quitline Callers
A NA study of Tobacco Use Cessation, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03927976: Completed NA study of Tobacco Use Cessation, sponsored by Case Comprehensive Cancer Center.
NCT03927976 is a NA study of Tobacco Use Cessation that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 35 participants, below the 884-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03927976, a NA study of Tobacco Use Cessation, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess the feasibility and acceptability of delivering an mHealth tobacco intervention among state quitline enrollees.
Primary Outcome
The program will be evaluated as feasible if 50% of those screened are eligible and interested in the video text program AND if 90% of those who are eligible and interested in the video text program will be able to engage in the program (some may need technical assistance).
Conditions Studied
Interventions
- BEHAVIORAL Path2Quit - culturally specific text message intervention
Study Locations (1)
Ohio
- Case Western Reserve University - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2020-02-10 |
| Phase | NA |
What the finished NCT03927976 record still lists
NCT03927976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 884-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 1 intervention - of which Path2Quit - culturally specific text message intervention is the first listed.
NCT03927976 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03927976 about?
NCT03927976 is a clinical study titled "Feasibility of a Culturally-Specific Video Text Cessation Intervention With AA Quitline Callers". Assess the feasibility and acceptability of delivering an mHealth tobacco intervention among state quitline enrollees.
What is the current status of trial NCT03927976?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-04-10. Estimated completion is 2020-02-10.
What conditions does trial NCT03927976 study?
This clinical trial studies the following conditions: Tobacco Use Cessation.
What interventions are being tested in trial NCT03927976?
The interventions under investigation include: Path2Quit - culturally specific text message intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03927976?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03927976 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03927976's enrollment target sits among peer trials
35 34th of 36 higher than 2 of 36 other Tobacco Use Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
Development of a Smoking Cessation Video Series
RECRUITING · NA
-
Trauma-Informed Care for Smoking Cessation for Pregnancy
RECRUITING · NA
-
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
RECRUITING · NA
-
Comprehensive Tobacco Cessation for Cancer Patients and Survivors
RECRUITING · NA
-
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI